ASAS Publications

  • Santos H, Henriques AR, Machado PM, López-Medina C, Dougados M, Canhao H, Rodrigues AM, Pimentel-Santos FM. Determinants of health-related quality of life and global functioning and health in axSpA, pSpA and PsA: results from the ASAS-PerSpA study. Rheumatology (Oxford). 2023 Sep 21:kead503. [Online ahead of print] PMID: 37738594
  • Michelena X, Zhao SS, Marco-Pascual S, Almirall M, Collantes-Estévez E, Font-Ugalde P, López-Medina C, Wei JCC, Morgan AW, Rodríguez J, Juanola X, Vázquez-Mellado J, Marzo-Ortega H. Diagnostic delay is associated with uveitis and inflammatory bowel disease in AS: a study of extra-musculoskeletal manifestations in SpA. Rheumatology (Oxford) 2024 Feb 1;63(2):430-435 (Open Access) PMID 37184889
  • Ziegeler K, Ulas ST, Poddubnyy D, Proft F, Rios Rodriguez V, Rademacher J, Hermann KGA, Diekhoff T. Anatomical variation of the sacroiliac joint carries an increased risk for erosion and bone marrow oedema in axial spondyloarthritis. Rheumatoloy (Oxford) 2023 Mar 1;62(3):1117-1127. PMID: 35532084
  • Ulas ST, Proft F, Diekhoff T, Rios Rodriguez V, Rademacher J, Poddubnyy D, Ziegeler K. HLA-B27 status and inflammatory MRI lesions of the sacroiliac joints: a post hoc analysis in patients without axial spondyloarthritis. RMD Open 2023 Sep;9(3):e003357. PMID: 37739448.
  • Ulas ST, Proft F, Diekhoff T, Rios V, Rademacher J, Protopopov M, Greese J, Eshed I, Adams LC, Hermann KGA, Ohrndorf S, Poddubnyy D, Ziegeler K. Sex-specific diagnostic efficacy on MRI in axial spondyloarthritis: challenging the “One Size Fits All” notion. RMD Open 2023 Oct;9(4):e003252. PMID: 37899091
  • Chaudhary H, López-Medina C, Khan MA, Dougados M, Magrey M. Clinical profile and treatment utilisation based on HLA-B*27 status in axial spondyloarthritis: results from ASAS-PerSpA study. RMD Open 2023 Jul;9(3):e003179. PMID: 37491128
  • Bordner A, Aouad T, López-Medina C, Yang S, Molto A, Talbot H, Dougados M, Feydy A. A deep learning model for the diagnosis of sacroiliitis according to Assessment of SpondyloArthritis International Society classification criteria with magnetic resonance imaging. Diagn Interv Imaging 2023 Jul-Aug;104(7-8):373-383. PMID: 37012131
  • Navarro-Compán V, Benavent D, Capelusnik D, van der Heijde D, Landewé RB, Poddubnyy D, van Tubergen A, Baraliakos X, Van den Bosch FE, van Gaalen FA, Gensler L, López-Medina C, Marzo-Ortega H, Molto A, Pérez-Alamino R, Rudwaleit M, van de Sande M, Sengupta R, Weber U, Ramiro S. ASAS consensus definition of early axial spondyloarthritis. Ann Rheum Dis. 2023 Jun 15:ard-2023-224232. doi: 10.1136/ard-2023-224232. [Epub ahead of print]. PMID: 37321799.
  • Granados REM, Ladehesa-Pineda ML, Puche-Larrubia MÁ, Escudero-Contreras A, Dougados M, Collantes-Estevez E, López-Medina C. Enthesitis indices identify different patients with this characteristic in axial and peripheral spondyloarthritis and also in psoriatic arthritis: ASAS-PerSpA data. Arthritis Res Ther. 2023;25(1):99 (Open Access) PMID 37291655
  • Capelusnik D, Benavent D, van der Heijde D, Landewé R, Poddubnyy D, van Tubergen A, Falzon L, Navarro-Compán V, Ramiro S. Treating spondyloarthritis early: does it matter? Results from a systematic literature review. Rheumatology (Oxford). 2023 Apr 3;62(4):1398-1409. PMID: 36099043
  • Ramiro S, Nikiphorou E, Sepriano A, Ortolan A, Webers C, Baraliakos X, Landewé RB, van der Heijde D. Response to: Correspondence on “ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update” by Ramiro et al. Ann Rheum Dis. 2023 Mar 6:ard-2023-223937. [Epub ahead of print] PMID: 36878690
  • Kwan YH, Phang JK, Woon TH, Liew JW, Dubreuil M, Proft F, Ramiro S, Molto A, Navarro-Compán V, de Hooge M, Meghnathi B, Ziade N, Zhao SS, Llop M, Baraliakos X, Fong W. Social Media Use Among Members of the Assessment of Spondyloarthritis International Society: Results of a Web-Based Survey. J Med Internet Res. 2023;25:e39155 (Open Access) PMID 36626201
  • Arevalo-Salaet M, López-Medina C, Moreno M, Navarro-Compan V, Calvet Fontova J, Llop M, Dougados M, Gratacós J. Association between HLA-B27 and peripheral spondyloarthritis phenotype: results from the ASAS perSpA study. RMD Open. 2022;8(2):e002696. (Open Access) PMID: 36597968
  • Ladehesa-Pineda ML, Ortega-Castro R, Puche-Larrubia MÁ, Granados REM, Dougados M, Collantes-Estévez E, López-Medina C. Smoking and alcohol consumption are associated with peripheral musculoskeletal involvement in patients with spondyloarthritis (including psoriatic arthritis). Results from the ASAS-PerSpA study. Semin Arthritis Rheum. 2022;58:152146. PMID: 36516482
  • Torgutalp M, Rios-Rodriguez V, Proft F, Protopopov M, Verba M, Rademacher J, Haibel H, Sieper J, Rudwaleit M, Poddubnyy D. Treatment with tumor necrosis factor inhibitors is associated with a time-shifted retardation of radiographic sacroiliitis progression in patients with axial spondyloarthritis: 10-year results from the German Spondyloarthritis Inception Cohort. Arthritis Rheumatol 2022 Sep;74(9):1515-1523 (Open Access). PMID 35437900
  • Ramiro S, Nikiphorou E, Sepriano A, Ortolan A, Webers C, Baraliakos X, Landewé RBM, Van den Bosch FE, Boteva B, Bremander A, Carron P, Ciurea A, van Gaalen FA, Géher P, Gensler L, Hermann J, de Hooge M, Husakova M, Kiltz U, López-Medina C, Machado PM, Marzo-Ortega H, Molto A, Navarro-Compán V, Nissen MJ, Pimentel-Santos FM, Poddubnyy D, Proft F, Rudwaleit M, Telkman M, Zhao SS, Ziade N, van der Heijde D. ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann Rheum Dis. 2023;82(1):19-34 (Open Access) PMID: 36270658
  • Webers C, Ortolan A, Sepriano A, Falzon L, Baraliakos X, Landewé RBM, Ramiro S, van der Heijde D, Nikiphorou E. Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis. Ann Rheum Dis. 2023;82(1):130-141. PMID: 36270657
  • Ortolan A, Webers C, Sepriano A, Falzon L, Baraliakos X, Landewé RB, Ramiro S, van der Heijde D, Nikiphorou E. Efficacy and safety of non-pharmacological and non-biological interventions: a systematic literature review informing the 2022 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis. Ann Rheum Dis. 2023;82(1):142-152 PMID: 36261247
  • Ono K, Kishimoto M, Deshpande GA, Fukui S, Kawaai S, Sawada H, Matsuura M, V Rios Rodriguez, Proft F, Tada K, Tamura N, Taniguchi Y, Hirata A, Kameda H, Tsuji S, Kaneko Y, Dobashi H, Okano T, Haji Y, Morita A, Okada M, Komagata Y, López-Medina C, Molto A, Dougados M, Hisamatsu T, Tomita T, Kaname S. Clinical characteristics of patients with spondyloarthritis and inflammatory bowel disease versus inflammatory bowel disease-related arthritis. Rheumatol Int 2022 Oct;42(10):1751-1766. PMID: 35532790
  • Benavent D, Capelusnik D, Ramiro S, Molto A, López-Medina C, Dougados M, Navarro-Compán V. Does gender influence outcome measures similarly in patients with spondyloarthritis? Results from the ASAS-perSpA study. RMD Open. 2022;8(2):e002514 PMID: 36096523
  • Llop M, Gratacós J, Moreno M, Arévalo M, Calvet J, Dougados M, López-Medina C. Uveitis in peripheral spondyloarthritis patients: an ancillary analysis of the ASAS-PerSpA study. Ther Adv Musculoskelet Dis. 2022;14:1759720X221119246. PMID: 36081747
  • Protopopov M, Proft F, Wichuk S, Machado PM, Lambert RG, Weber U, Juhl Pedersen S, Østergaard M, Sieper J, Rudwaleit M, Baraliakos X, Maksymowych WP, Poddubnyy D. Comparing MRI and conventional radiography for the detection of structural changes indicative of axial spondyloarthritis in the ASAS cohort. Rheumatology (Oxford). 2023;62(4):1631-1635 PMID: 35951746
  • Protopopov M, Proft F, Wichuk S, Machado PM, Lambert RG, Weber U, Pedersen SJ, Ostergaard M, Sieper J, Rudwaleit M, Baraliakos X, Maksymowych WP, Poddubnyy D. Rheumatology (Oxford) 2023;62(4):1631-1635. PMID: 35951746
  • Navarro-Compán V, Boel A, Boonen A, Mease PJ, Dougados M, Kiltz U, Landewé RBM, Baraliakos X, Bautista-Molano W, Chiowchanwisawakit P, Dagfinrud H, Fallon L, Garrido-Cumbrera M, Gensler L, ElZorkany BK, Haroon N, Kwan YH, Machado PM, Maksymowych W, Molto A, de Peyrecave N, Poddubnyy D, Protopopov M, Ramiro S, Song IH, van Weely S, van der Heijde D. Instrument selection for the ASAS core outcome set for axial spondyloarthritis. Ann Rheum Dis. 2023;82(6):763-772 PMID: 35680390
  • Fitzgerald GE, Maguire S, Lopez-Medina C, Dougados M, O’Shea FD, Haroon N. Tender to touch-Prevalence and impact of concomitant fibromyalgia and enthesitis in spondyloarthritis: An ancillary analysis of the ASAS PerSpA study. Joint Bone Spine. 2022 Nov;89(6):105420 (Open Access) PMID: 35636706
  • Baraliakos X, Østergaard M, Lambert RG, Eshed I, Machado PM, Pedersen SJ, Weber U, de Hooge M, Sieper J, Poddubnyy D, Rudwaleit M, van der Heijde D, Landewé RB, Maksymowych WP. MRI lesions of the spine in patients with axial spondyloarthritis: an update of lesion definitions and validation by the ASAS MRI working group. Ann Rheum Dis. 2022 May 24:annrheumdis-2021-222081. doi: 10.1136/annrheumdis-2021-222081. [Epub ahead of print] (Open Access) PMID: 35609977
  • Ziegeler K, Ulas ST, Poddubnyy D, Proft F, Rios Rodriguez V, Rademacher J, Hermann KGA, Diekhoff T. Anatomical variation of the sacroiliac joint carries an increased risk for erosion and bone marrow oedema in axial spondyloarthritis. Rheumatology (Oxford). 2023;62(3):1117-1123 PMID: 35532084
  • Ziade N, Rassi J, Elzorkany B, Lopez-Medina C, Gamal SM, Hlais S, Dougados M, Baraliakos X. What is peripheral spondyloarthritis? Identifying proportion, phenotype and burden in post hoc analysis of the ASAS-PerSpA study. Semin Arthritis Rheum. 2022;55:152012. PMID: 35489171
  • Kiltz U, Wiatr T, Redeker I, Baraliakos X, Fedorov K, Braun J. Effects of patient and disease characteristics on global functioning in patients with axial spondyloarthritis in routine care. Semin Arthritis Rheum. 2022;55:152006. PMID: 35472664
  • Izci Duran T, Torgutalp M, Rios Rodriguez V, Proft F, López-Medina C, Dougados M, Poddubnyy D. The impact of psoriasis on the clinical characteristics, disease burden and treatment patterns of peripheral spondyloarthritis. Rheumatology (Oxford). 2022;62(1):135-146 PMID 35451472
  • Torgutalp M, Rios Rodriguez V, Proft F, Protopopov M, Verba M, Rademacher J, Haibel H, Sieper J, Rudwaleit M, Poddubnyy D. Treatment With Tumor Necrosis Factor Inhibitors Is Associated With a Time-Shifted Retardation of Radiographic Sacroiliitis Progression in Patients With Axial Spondyloarthritis: 10-Year Results From the German Spondyloarthritis Inception Cohort. Arthritis Rheumatol. 2022 Sep;74(9):1515-1523. PMID: 35437900
  • Pons M, Chevret S, Briot K, d’Agostino MA, Roux C, Dougados M, Molto A. Evaluation of long-term TNFi effectiveness after a first switch in early axial spondyloarthritis considering time-varying prescription bias: an inverse-probability weighting analysis of the DESIR cohort. RMD Open 2022;8(1):e001846 (Open Access). PMID: 35042728
  • Benavent D, Capelusnik D, van der Heijde D, Landewé R, Poddubnyy D, van Tubergen A, Falzon L, Ramiro S, Navarro-Compán V. How is early spondyloarthritis defined in the literature? Results from a systematic review. Semin Arthritis Rheum. 2022 Aug:55:152032. PMID: 35667332
  • Boel A, van Lunteren M, López-Medina C, Sieper J, van der Heijde D, van Gaalen FA. Geographical prevalence of family history in patients with axial spondyloarthritis and its association with HLA-B27 in the ASAS-PerSpA study. RMD Open. 2022 Mar;8(1):e002174 (Open Access) PMID: 35301267
  • Diekhoff T, Lambert R, Hermann KG. MRI in axial spondyloarthritis: understanding an ‘ASAS-positive MRI’ and the ASAS classification criteria. Skeletal Radiol. 2022 Sep;51(9):1721-1730 (Open Access) PMID 35199195
  • Marnas G, Bernardy C, Colę A, Bellier A, Chapuis P, Romand X, Gossec L, Lefèvre-Colau MM, Foltz V, Richette P, Dieude P, Molto A, Baillet A. Spine abnormalities associated with bone edema on sacroiliac joints MRI in patients with non-inflammatory chronic back pain. Joint Bone Spine 2022 Nov:89(6):105436. PMID: 35777553
  • Poddubnyy D, Baraliakos X, van den Bosch F, Braun J, Coates LC, Chandran V, Diekhoff T, van Gaalen FA, Gensler LS, Goel N, Gottlieb AB, van der Heijde D, Helliwell PS, Hermann KGA, Jadon D, Lambert RG, Maksymowych WP, Mease P, Nash P, Proft F, Protopopov M, Sieper J, Torgutalp M, Gladman DD. Axial Involvement in Psoriatic Arthritis cohort (AXIS): the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). Ther Adv Musculoskelet Dis. 2021; 13:1759720X211057975 (Open Access) PMID: 34987619
  • Kwan YH, Tan L, Tan CS, López-Medina C, Dougados M, Proft F, Rios-Rodriguez V, Phang JK, Chew EH, Østbye T, Thumboo J, Fong W. Elucidating the role of a positive family history in differentiating between axial and peripheral spondyloarthritis: an ancillary analysis of the ASAS-PerSpA study. Clin Exp Rheumatol. 2022;40(9):1762-1768 PMID: 34905484
  • López-Medina C, Chevret S, Molto A, Sieper J, Duruöz T, Kiltz U, Elzorkany B, Hajjaj-Hassouni N, Burgos-Vargas R, Maldonado-Cocco J, Ziade N, Gavali M, Navarro-Compan V, Luo SF, Biglia A, Tae-Jong K, Kishimoto M, Pimentel-Santos FM, Gu J, Muntean L, van Gaalen FA, Geher P, Magrey M, Ibáñez-Vodnizza SE, Bautista-Molano W, Maksymowych W, Machado PM, Landewé R, van der Heijde D, Dougados M. Identification of clinical phenotypes of peripheral involvement in patients with spondyloarthritis, including psoriatic arthritis: a cluster analysis in the worldwide ASAS-PerSpA study. RMD Open. 2021;7:e001728 (Open Access) PMID: 34750246
  • Carbo MJ, Paap D, Maas F, Baron AJ, van Oberbeeke LC, Siderius M, Bootsma H, Wink F, Arends S, Spoorenberg A. The mSQUASH; a valid, reliable and responsive questionnaire for daily physical activity in patients with axial spondyloarthritis. Semin Arthritis Rheum 2021 Aug;51(4):719-727. PMID: 34144381
  • Puche-Larrubia MÁ, Ladehesa-Pineda L, Font-Ugalde P, Escudero-Contreras A, Moltó A, López-Medina C, Collantes-Estévez E. Distribution of comorbidities in spondyloarthritis with regard to the phenotype and psoriasis: data from the ASAS-COMOSPA study. Ther Adv Musculoskelet Dis. 2021;13:1759720X211045263 (Open Access) PMID: 34567275
  • Protopopov M, Proft F, Sepriano A, Landewé R, van der Heijde D, Maksymowych WP, Baraliakos X, Sieper J, Rudwaleit M, Poddubnyy D. Radiographic sacroiliitis progression in axial spondyloarthritis: central reading of 5 year follow-up data from the assessment of spondyloarthritis international society cohort. Rheumatology (Oxford) 2021;60(5):2478-2480 (Open Access). PMID: 3353772
  • Kiltz U, Boonen A, van der Heijde D, Bautista-Molano W, Burgos Vargas R, Chiowchanwisawakit P, El-Zorkany B, Gaydukova I, Geher P, Gossec L, Gilio M, Grazio S, Gu J, Khan MA, Kim TJ, Maksymowych WP, Marzo-Ortega H, Navarro-Compán V, Ozgocmen S, Patrikos D, Pimentel-Santos FM, Reveille J, Schirmer M, Stebbings S, Van den Bosch F, Weber U, Braun J. Development of an environmental contextual factor item set relevant to global functioning and health in patients with axial spondyloarthritis. Rheumatology (Oxford). 2022;61(5):2054-2062 PMID 34534275
  • Kishimoto M, Ono K, Fukui S, Kawaai S, Deshpande GA, Yoshida K, Ichikawa N, Kaneko Y, Kawasaki T, Matsui K, Morita M, Tada K, Takizawa N, Tamura N, Taniguchi A, Taniguchi Y, Tsuji S, Okada M, Kobayashi S, Komagata Y, López-Medina C, Molto A, van der Heijde D, Dougados M, Tomita T, Kaname S. Clinical characteristics of non-radiographic versus radiographic axial spondyloarthritis in Asia and non-radiographic axial spondyloarthritis in other regions: results of the cross-sectional ASAS-COMOSPA study. RMD Open. 2021;7:e001752 (Open Access) PMID: 34531305
  • Navarro-Compán V, Boel A, Boonen A, Mease P, Landewé R, Kiltz U, Dougados M, Baraliakos X, Bautista-Molano W, Carlier H, Chiowchanwisawakit P, Dagfinrud H, de Peyrecave N, El-Zorkany B, Fallon L, Gaffney K, Garrido-Cumbrera M, Gensler LS, Haroon N, Kwan YH, Machado PM, Maksymowych WP, Poddubnyy D, Protopopov M, Ramiro S, Shea B, Song IH, van Weely S, van der Heijde D. The ASAS-OMERACT core domain set for axial spondyloarthritis. Semin Arthritis Rheum. 2021;51:1342-1349 PMID: 34489113
  • Renson T, de Hooge M, de Craemer AS, Deroo L, Lukasik Z, Carron P, Herregods N, Jans L, Colman R, van den Bosch F, Elewaut D. Progressive increase in sacroiliac joint and spinal lesions detected on magnetic resonance imaging in healthy individuals in relation to age. Arthritis Rheumatol 2022 Sep;74(9):1506-1514. PMID: 35436391
  • Pons M, Dougados M, Costeodat-Chalumeau N, Briot K, Goupille P, Roux C, Molto A. Pregnancy rates and outcomes in early axial spondyloarthritis: an analysis of the DESIR cohort. Joint Bone Spine 2021;88(2):105075. PMID: 32947013
  • Boel A, Navarro-Compán V, Boonen A, Mease P, Kiltz U, Dougados M, Landewé R, van der Heijde D. Domains to Be Considered for the Core Outcome Set of Axial Spondyloarthritis: Results From a 3-round Delphi Survey. J Rheumatol. 2021 Dec;48(12):1810-1814. PMID 34334361
  • Capelusnik D, Zhao SS, Boonen A, Ziade N, Medina CL, Dougados M, Nikiphorou E, Ramiro S. Individual and country-level socioeconomic factors and health outcomes in spondyloarthritis: analysis of the ASAS perSpA study. Rheumatology (Oxford). 2022;61(5):2043-2053 PMID: 34387300
  • Boel A, López-Medina C, van der Heijde DMFM, van Gaalen FA. Age at onset in axial spondyloarthritis around the world: data from the Assessment in SpondyloArthritis international Society Peripheral Involvement in Spondyloarthritis study. Rheumatology (Oxford). 2022;61(4):1468-1475 (Open Access) PMID: 34260699
  • Ziegeler K, Hermann KGA, Diekhoff T. Anatomical Joint Form Variation in Sacroiliac Joint Disease: Current Concepts and New Perspectives. Curr Rheumatol Rep. 2021;23:60 (Open Access) PMID: 34216295
  • Zhao SS, Nikiphorou E, Boonen A, López-Medina C, Dougados M, Ramiro S. Association between individual and country-level socioeconomic factors and work participation in spondyloarthritis including psoriatic arthritis: Analysis of the ASAS-perSpA study. Semin Arthritis Rheum. 2021;51:804-812 (Open Access) PMID: 34153894
  • Ortolan A, Ramiro S, van Gaalen F, Kvien TK, Landewe RBM, Machado P, Ruyssen-Witrand A, van Tubergen A, Bastiaenen C, van der Heijde D. Development and validation of an alternative ankylosing spondylitis disease activity score when patient global assessment is unavailable. Rheumatology (Oxford) 2021 Feb1;60(2):638-648 (Open Access). PMID: 32572483
  • Benavent D, Plasencia C, Poddubnyy D, Kishimoto M, Proft F, Sawada H, López-Medina C, Dougados M, Navarro-Compán V. Unveiling axial involvement in psoriatic arthritis: An ancillary analysis of the ASAS-perSpA study. Semin Arthritis Rheum. 2021;51:766-774 PMID: 34144387 
  • Ziadé N, El Hajj J, Rassi J, Hlais S, Lopez-Medina C, Gamal SM, Elzorkany B, Dougados M, Baraliakos X. Root Joint Involvement in Spondyloarthritis: A Post-hoc Analysis from the International ASAS-PerSpA Study. Rheumatology (Oxford). 2022;61(2):667-678 PMID: 33905488
  • Maksymowych WP, Lambert RG, Baraliakos X, Weber U, Machado PM, Pedersen SJ, Hooge M, Sieper J, Wichuk S, Poddubnyy D, Rudwaleit M, van der Heijde D, Landewe R, Eshed I, Ostergaard M. Data-driven definitions for active and structural MRI lesions in the sacroiliac joint in spondyloarthritis and their predictive utility. Rheumatology (Oxford). 2021;60:4778-4789 PMID: 33523107
  • López-Medina C, Molto A, Sieper J, Duruöz T, Kiltz U, Elzorkany B, Hajjaj-Hassouni N, Burgos-Vargas R, Maldonado-Cocco J, Ziade N, Gavali M, Navarro-Compan V, Luo SF, Monti S, Tae-Jong K, Kishimoto M, Pimentel-Santos FM, Gu J, Schiotis R, van Gaalen FA, Geher P, Magrey M, Ibáñez Vodnizza SE, Bautista-Molano W, Maksymowych W, Machado PM, Landewé R, van der Heijde D, Dougados M. Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study. RMD Open. 2021;7:e001450 (Open Access) PMID: 33462157
  • Andreasen RA, Kristensen LE, Baraliakos X, Strand V, Mease PJ, de Wit M, Ellingsen T, Hansen I, Kirkham J, Wells, GA, Tugwell P, Maxwell L, Boers M, Egstrup K, Christensen R. Assessing the effect of interventions for axial spondyloarthritis according to the endorsed ASAS/OMERACT core outcome set: a meta-research study of trials included in Cochrane reviews. Arthritis Res Ther. 2020; 22:177 (Open Access) PMID: 32711571
  • Ortolan A, Ramiro S, van Gaalen F, Kvien TK, Landewe RBM, Machado PM, Ruyssen-Witrand A, van Tubergen A, Bastiaenen C, van der Heijde D. Development and validation of an alternative ankylosing spondylitis disease activity score when patient global assessment is unavailable. Rheumatology (Oxford). 2021;60(2):638-648 (Open Access) PMID: 32572483
  • Maksymowych WP, Pedersen SJ, Weber U, Baraliakos X, Machado PM, Eshed I, de Hooge M, Sieper J, Wichuk S, Rudwaleit M, van der Heijde D, Landewé R, Poddubnyy D, Ostergaard M, Lambert R. Central reader evaluation of MRI scans of the sacroiliac joints from the ASAS classification cohort: discrepancies with local readers and impact on the performance of the ASAS criteria. Ann Rheum Dis. 2020;79:935–942 PMID: 32371388
  • van Bentum R, Ibáñez-Vodnizza SE, Poblete de la Fuente, Valenzuela-Aldridge F, Navarro-Compán V, Rusman TR, Wee MMT, Valenzuela-Letelier O, van Weely SFE, van der Horst-Bruinsma IE. The Ankylsoing Spondylitis Perfomance Index: reliability and feasibility of an objective test for physical functioning. J Rheumatol 2020 Oct 1;47(10):1475-1482. PMID: 32007935
  • Liew JW, Ward MM, Reveille JD, Weisman M, Brown MA, Lee MJ, Rahbar M, Heckbert SR, Gensler LS. Nonsteroidal anti-inflammatory drug use an association with incident hypertension in ankylosing spondylitis. Arthritis Care Res (Hoboken) 2020 Nov;72(11):1645-1652 (Open Access). PMID: 31529687
  • Arévalo-Salaet M, López-Medina C, Martinez-Losa  MM, Moltó A, Font P, Collantes-Estevez E, Gratacós J.  Role of HLA-B27 in the comorbidities observed in Axial Spondyloarthritis: Data from COMOSPA. Joint Bone Spine. 2020;87:445-448 PMID: 32251735
  • Renson T, Depicker A, de Craemer AS, Deron L, Varkas G, de Hooge M, Carron P, Jans L, Herregods N, Dehaene I, Vandenberghe G, Rollens K, van den Bosch, Elewaut D. High prevalence of spondyloarthritis-like MRI lesions in postpartum women: a prospective analysis in relation to maternal, child and birth characteristics. Ann Rheum Dis 2020 Jul;79(7):929-934. PMID: 32299794
  • Stolwijk C, Essers I, van den Bosch F, Dougados M, Etcheto A, van der Heijde D, Landewé R, Molto A, van Tubergen A, Boonen A. Validation of the self-administered comorbidity questionnaire adjusted for spondyloarthritis: results from the ASAS-COMOSPA study.
    Rheumatology (Oxford). 2019; 59:1632-1639. (Open Access) PMID: 31665462
  • Kiltz U, Landewé RBM, van der Heijde D, Rudwaleit M, Weisman MH, Akkoc N, Boonen A, Brandt J, Carron P, Dougados M, Gossec L, Jongkees M, Machado PM, Marzo-Ortega H, Molto A, Navarro-Compán V, Niederman K, Sampaio-Barros PD, Slobodin G, Van den Bosch FE, van Tubergen A, van Weely S, Wiek D, Braun J. Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis. Ann Rheum Dis. 2019; 79:193-201. (Open Access) PMID: 31604704
  • Maksymowych WP, Lambert RG, Østergaard M, Pedersen SJ, Machado PM, Weber U, Bennett AN, Braun J, Burgos-Vargas R, de Hooge M, Deodhar AA, Eshed I, Jurik AG, Hermann KA, Landewé RB, Marzo-Ortega H, Navarro-Compán V, Poddubnyy D, Reijnierse M, Rudwaleit M, Sieper J, Van den Bosch FE, van der Heijde D, van der Horst-Bruinsma IE, Wichuk S, Baraliakos X. MRI lesions in the sacroiliac joints of patients with spondyloarthritis: an update of definitions and validation by the ASAS MRI working group. Ann Rheum Dis. 2019;78:1550-1558. PMID: 31422357
  • Boel A, Molto A, van der Heijde D, Ciurea A, Dougados M, Gensler LS, Santos MJ, De Miguel E, Poddubnyy D, Rudwaleit M, van Tubergen A, van Gaalen FA, Ramiro S. Do patients with axial spondyloarthritis with radiographic sacroiliitis fulfil both the modified New York criteria and the ASAS axial spondyloarthritis criteria? Results from eight cohorts. Ann Rheum Dis. 2019;78:1545-1549. (Open Access) PMID: 31362994
  • Essers I, Hiligsmann M, Kiltz U, Bansback N, Braun J, van der Heijde D, Boonen A. Development of one general and six country-specific algorithms to assess societal health utilities based on ASAS HI. RMD Open. 2019;5:e000872. (Open Access) PMID: 31245046
  • López-Medina C, Moltó A, Dougados M. Peripheral Manifestations in Spondyloarthritis and their Effect: An Ancillary Analysis of the ASAS-COMOSPA Study. J Rheumatol. 2019; 47:211-217 PMID: 30988127
  • Derakhshan MH, Goodson NJ, Packham J, Sengupta R, Molto A, Marzo-Ortega H, Siebert S; BRITSpA and the ASAS-COMOSPA Investigators. Association of Diverticulitis with Prolonged Spondyloarthritis: An Analysis of the ASAS-COMOSPA International Cohort. J Clin Med. 2019;8:281. (Open Access) PMID: 30813544
  • Putrik P, Ramiro S, Moltó A, Keszei AP, Norton S, Dougados M, van der Heijde D, Landewé RBM, Boonen A. Individual-level and country-level socioeconomic determinants of disease outcomes in SpA: multinational, cross-sectional study (ASAS-COMOSPA). Ann Rheum Dis. 2019;78:486-493. PMID: 30674477
  • Derakhshan MH, Goodson NJ, Packham JC, Sengupta R, Molto A, Marzo-Ortega H, Siebert S; BRITSpA and COMOSPA Investigators. Increased Risk of Hypertension Associated with Spondyloarthritis Disease Duration: Results from the ASAS-COMOSPA Study. J Rheumatol. 2019;46:701-709. PMID: 30647169
  • Meghnathi B, Saruax A, Dougados M, Moltó A. Evaluation of the predictive validity of the ASAS axial spondyloarthritis criteria in the DESIR cohort. Clin Exp Rheumatol 2019 Sep-Oct;37(5):797-802
  • Molto A, Gossec L, Lefèvre-Colau MM, Foltz V, Beaufort R, Laredo JD, Richette P, Dieude P, Goupille P, Feydy A, Dougados M. Evaluation of the performances of “typical” imaging abnormalities of axial spondyloarthritis: results of the cross-sectional ILOS-DESIR study. RMD Open May 28;5(1):e000918. PMID: 31245053
  • Sepriano A, Ramiro S, Landewé R, Dougados M, van der Heijde D, Rudwaleit M. Is active sacroiliitis on MRI associated with radiographic damage in axial spondyloarthritis? Real-life data from the ASAS and DESIR cohorts. Rheumatology (Oxford). 2019;58:798-802. PMID: 30544144
  • Navarro-Compan V, Oton T, Loza E, Almodovar R, Ariza-Ariza R, Bautista-Molano W, Burgos-Vargas R, Collantes-Estevez E, de Miguel E, Gonzalez-Fernandez C, Gratacos J, Ibanez S, Juanola X, Maldonado-Cocco J, Molto A, Mulero J, Pacheco-Tena C, Ramos-Remus C, Sanz-Sanz J, Valle-Onate R, Zarco P, Marzo-Ortega H. Assessment of SpondyloArthritis International Society (ASAS) Consensus on Spanish Nomenclature for Spondyloarthritis. Reumatologia clinica. 2018, 16(5 Pt 1):333-338 PMID: 30193774
  • van Lunteren M, Sepriano A, Landewé R, Sieper J, Rudwaleit M, van der Heijde D, van Gaalen F. Do ethnicity, degree of family relationship, and the spondyloarthritis subtype in affected relatives influence the association between a positive family history for spondyloarthritis and HLA-B27 carriership? Results from the worldwide ASAS cohort. Arthritis Res Ther. 2018;20:166. (Open Access) PMID: 30075809
  • Varkas G, de Hooge M, Renson T, De Mits S, Carron P, Jacques P, Moris M, Souverijns G, Jans J, Elewaut D, van den Bosch F. Effect of mechanical stress on magnetic resonance imaging of the sacroiliac joints: assessment of military recruits by magnetic resonance imaging study. Rheumatology (Oxford). 2018 Mar 1;57(3):508-513. PMID: 29329434
  • Diekhoff T, Greese J, Sieper J, Poddubnyy D, Hamm B, Hermann KGA. Improved detection of erosions in the sacroiliac joints on MRI with volumetric interpolated breath-hold examination (VIBE): results from the SIMACT study. Ann Rheum Dis. 2018 Nov;77(11):1585-1589. PMID: 30097454
  • Rodrigues Manica S, Sepriano A, Ramiro S, Pimentel Santos F, Putrik P, Nikiphorou E, Norton S, Molto A, Dougados M, van der Heijde D, Landewé RBM, van den Bosch FE, Boonen A. Work participation in spondyloarthritis across countries: analysis from the ASAS-COMOSPA study. Ann Rheum Dis. 2018;77:1303-1310. PMID: 29860232
  • Kiltz U, van der Heijde D, Boonen A, Akkoc N, Bautista-Molano W, Burgos-Vargas R, Wei JC, Chiowchanwisawakit P, Dougados M, Duruoz MT, Elzorkany BK, Gaydukova I, Gensler LS, Gilio M, Grazio S, Gu J, Inman RD, Kim TJ, Navarro-Compan V, Marzo-Ortega H, Ozgocmen S, Pimentel Dos Santos F, Schirmer M, Stebbings S, Van den Bosch FE, van Tubergen A, Braun J. Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis. Ann Rheum Dis. 2018;77:1311-1317. (Open Access) PMID: 29858176
  • Couderc M, Pereira B, Molto A, Tiple A, Soubrier M, Dougados M. The Prevalence of Renal Impairment in Patients With Spondyloarthritis: Results From the International ASAS-COMOSPA Study. J Rheumatol 2018;45:795-801 PMID: 29657148
  • Machado PM, Landewé R, van der Heijde D, Assessment of SpondyloArthritis international Society (ASAS). Ankylosing Spondylitis Disease Activity Score (ASDAS): 2018 update of the nomenclature for disease activity states. Ann Rheum Dis. 2018;77:1539-1540 (Toll-Free Link). PMID: 29453216
  • Bautista-Molano W, Landewé R, Burgos-Vargas R, Maldonado-Cocco J, Moltó A, van den Bosch F, Valle-Oñate R, Dougados M, van der Heijde D. Prevalence of Comorbidities and Risk Factors for Comorbidities in Patients with Spondyloarthritis in Latin America: A Comparative Study with the General Population and Data from the ASAS-COMOSPA Study. J Rheumatol. 2018;45:206-12. PMID: 29247152
  • Nikiphorou E, van der Heijde D, Norton S, Landewé RB, Molto A, Dougados M, Van den Bosch FE, Ramiro S. Inequity in biological DMARD prescription for spondyloarthritis across the globe: results from the ASAS-COMOSPA study. Ann Rheum Dis. 2018;77:405-11. PMID: 29222349
  • Fernandes S, Etcheto A, van der Heijde D, Landewé R, van den Bosch F, Dougados M, Moltó A. Vitamin D status in spondyloarthritis: results of the ASAS-COMOSPA international study. Clin Exp Rheumatol. 2018;36:210-214. PMID: 29148411
  • Nikiphorou E, Ramiro S, van der Heijde D, Norton S, Moltó A, Dougados M, van den Bosch F, Landewé R; ASAS-COMOSPA Task Force. Association of comorbidities in spondyloarthritis with poor function, work disability, and quality of life: results from the Assessment of Spondyloarthritis International Society Comorbidities in Spondyloarthritis Study. Arthritis Care Res (Hoboken). 2018;70:1257-1262. PMID: 29125900
  • Meghnathi B, Claudepierre P, Dougados M, Moltó A. Evaluation of extreme patient-reported outcome in early spondyloarthritis and its impact on the effect of TNF alpha blockers treatment. Clin Exp Rheumatol 2018 Nov-Dec; 36(6):1043-1048
  • Chan J, Sari I, Salonen D, Silverberg MS, Harmon N, Inman RD. Prevalence of sacroiliitis in inflammatory bowel disease using a standardised computed tomography scoring system. Arthritis Care Res (Hoboken) 2018 May;70(5):807-810 (Open Access). PMID: 28732137
  • Molto A, Gossec L, Meghnathi B, Landewé RBM, van der Heijde D, Atagunduz P, Elzorkany BK, Akkoc N, Kiltz U, Gu J, Wei JCC, Dougados M; ASAS-FLARE study group. An Assessment in SpondyloArthritis International Society (ASAS)-endorsed definition of clinically important worsening in axial spondyloarthritis based on ASDAS. Ann Rheum Dis. 2018;77:124-7. (Toll-Free Link) PMID: 29038299
  • López-Medina C, Jiménez-Gómez Y, Moltó A, Schiotis RE, Marzo-Ortega H, van Gaalen FA, Ozgocmen S, Dougados M, Calvo-Gutiérrez J, Castro-Villegas MC, Collantes-Estévez E, Font-Ugalde P; ASAS-COMOSPA task force. Cardiovascular risk factors in patients with spondyloarthritis from Northern European and Mediterranean countries: An ancillary study of the ASAS-COMOSPA project. Joint Bone Spine. 2018;85:447-453. PMID: 28754402
  • Sepriano A, Rubio R, Ramiro S, Landewé R, van der Heijde D. Performance of the ASAS classification criteria for axial and peripheral spondyloarthritis: a systematic literature review and meta-analysis. Ann Rheum Dis. 2017;76:886-890. (Toll-Free Link) PMID: 28179264
  • Bautista-Molano W, Landewé RBM, Serna C, Valle-Oñate R, van der Heijde D. Factors associated with the decisions of the rheumatologist to order sacroiliac joints magnetic resonance imaging (SI-MRI) or HLA-B27 testing in the diagnostic work-up of patients with spondyloarthritis in clinical practice. Clin Exp Rheumatol.2017 Jan-Feb;35(1):122-128 (Open Access). PMID 27782870
  • Herregods N, Dehoorne J, van den Bosch F, Jaremko JL, Vlaenderen JV, Joos R, Baraliakos X, Varkas G, Verstraete K, Elewaut D, Jans L. ASAS definition for sacroiliitis on MRI in SpA: applicable to children? Pediatr Rheumatol Online J. 2017 Apr 11;15(1):24. (Open Access). PMID: 28399875
  • Ibáñez-Vodnizza S, Cisman IM, van Denderen C, Lems WF, Jaime F, Nurmohamed MT, van der Horst-Bruinsma I. Muscule wasting in male TNF-alpha blocker naïve ankylosing spondylitis patients: a comparison of gender differences in body composition. Rheumatology (Oxford) 2017 Sep 1;56(9):1566-1572. PMID: 28605535
  • Regel A, Sepriano A, Baraliakos X, van der Heijde D, Braun J, Landewé R, Van den Bosch F, Falzon L, Ramiro S. Efficacy and safety of non-pharmacological and non-biological pharmacological treatment: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis. RMD Open. 2017 Jan 27;3(1):e000397. (Open Access) PMID: 28176966
  • Diekhoff T, Hermann KG, Greese J, Schwenke C, Poddubnyy D, Hamm B, Sieper J. Comparison of MRI with radiography for detecting structural lesions of the sacroiliac joint using CT as standard of reference: results from the SIMACT study. Ann Rheum Dis 2017 Sep;76(9):1502-1508. PMID: 28283515
  • Sepriano A, Regel A, van der Heijde D, Braun J, Baraliakos X, Landewé R, Van den Bosch F, Falzon L, Ramiro S. Efficacy and safety of biological and targeted-synthetic DMARDs: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis. RMD Open. 2017 Jan 27;3(1):e000396. (Open Access) PMID: 28176964
  • van der Heijde D, Ramiro S, Landewé R, Baraliakos X, Van den Bosch F, Sepriano A, Regel A, Ciurea A, Dagfinrud H, Dougados M, van Gaalen F, Géher P, van der Horst-Bruinsma I, Inman RD, Jongkees M, Kiltz U, Kvien TK, Machado PM, Marzo-Ortega H, Molto A, Navarro-Compàn V, Ozgocmen S, Pimentel-Santos FM, Reveille J, Rudwaleit M, Sieper J, Sampaio-Barros P, Wiek D, Braun J. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis. 2017;76:978-91. (Open Access) PMID: 28087505
  • Sepriano A, Ramiro S, van der Heijde D, Ávila-Ribeiro P, Fonseca R, Borges J, Teixeira L, Carvalho PD, Cerqueira M, Neves J, Meirinhos T, Barcelos A, Sequeira G, Salvador MJ, Canas da Silva J, Santos H, Bernardes M, Vieira-Sousa E, Canhao H, Branco JC; Pimentel-Santos F, Landewé R. Effect of comedication with conventional synthetic disease-modifying anti rheumatic drugs on retention of tumor necrosis factor inhibitors in patients with spondyloarthritis: a prospective cohort study. Arthritis Rheumatol 2016 Nov;68(11):2671-2679 (Open Access). PMID 27273894
  • Kiltz U, van der Heijde D, Boonen A, Bautista-Molano W, Burgos-Vargas R, Chiowchanwisawakit P, Duruoz T, El-Zorkany B, Essers I, Gaydukova I, Géher P, Gossec L, Grazio S, Gu J, Khan MA, Kim TJ, Maksymowych WP, Marzo-Ortega H, Navarro-Compán V, Olivieri I, Patrikos D, Pimentel-Santos FM, Schirmer M, van den Bosch F, Weber U, Zochling J, Braun J. Measuring impairments of functioning and health in patients with axial spondyloarthritis by using the ASAS Health Index and the Environmental Item Set: translation and cross-cultural adaptation into 15 languages. RMD Open. 2016 Oct 4;2(2):e000311. (Open Access) PMID: 27752358
  • Sepriano A, Landewé R, van der Heijde D, Sieper J, Akkoc N, Brandt J, Braun J, Collantes-Estevez E, Dougados M, Fitzgerald O, Huang F, Gu J, Kirazli Y, Maksymowych WP, Marzo-Ortega H, Olivieri I, Ozgocmen S, Roussou E, Scarpato S, Sørensen IJ, Valle-Oñate R, Van den Bosch F, van der Horst-Bruinsma I, Weber U, Wei J, Rudwaleit M; ASAS. Predictive validity of the ASAS classification criteria for axial and peripheral spondyloarthritis after follow-up in the ASAS cohort: a final analysis. Ann Rheum Dis. 2016;75:1034-42. (Toll-Free Link) PMID: 26865599
  • Chan J, Sari I, Salonen D, Inman RD, Haroon N. Development of a screening tool for the identification of sacroiliitis in computed tomography scans of the abdomen. J Rheumatol 2016 Sep;43(9):1687-94 (Open Access) PMID: 27422894
  • Gossec L, Portier A, Landewé R, Etcheto A, Navarro-Compán V, Kroon F, van der Heijde D, Dougados M. Preliminary definitions of ‘flare’ in axial spondyloarthritis, based on pain, BASDAI and ASDAS-CRP: an ASAS initiative. Ann Rheum Dis. 2016;75:991-6. (Open Access) PMID: 26847821
  • Poddubnyy D, Fedorova A, Listing J, Haibel H, Baraliakos X, Braun J, Sieper J. Physical function and spinal mobility remain stable despite radiographic spinal progression in patients with ankylosing spondylitis treated with TNF alpha inhibitors for up to 10 years. J Rheumatol 2016 Dec;43(12):2142-2148 (Open Access). PMID 27803139
  • Lambert RG, Bakker PA, van der Heijde D, Weber U, Rudwaleit M, Hermann KG, Sieper J, Baraliakos X, Bennett A, Braun J, Burgos-Vargas R, Dougados M, Pedersen SJ, Jurik AG, Maksymowych WP, Marzo-Ortega H, Østergaard M, Poddubnyy D, Reijnierse M, van den Bosch F, van der Horst-Bruinsma I, Landewé R. Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group. Ann Rheum Dis. 2016;75:1958-1963. (Toll-Free Link) PMID: 26768408
  • Moltó A, Etcheto A, van der Heijde D, Landewé R, van den Bosch F, Bautista Molano W, Burgos-Vargas R, Cheung PP, Collantes-Estevez E, Deodhar A, El-Zorkany B, Erdes S, Gu J, Hajjaj-Hassouni N, Kiltz U, Kim TH, Kishimoto M, Luo SF, Machado PM, Maksymowych WP, Maldonado-Cocco J, Marzo-Ortega H, Montecucco CM, Ozgoçmen S, van Gaalen F, Dougados M. Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study. Ann Rheum Dis. 2016;75:1016-23. (Toll-Free Link) PMID: 26489703
  • Castillo-Ortiz JD, Ramiro S, Landewé R, van der Heijde D, Dougados M, van den Bosch F, Boonen A. Work outcome in patients with ankylosing spondylitis: results from a 12-year follow up of an international study. Arthritis Care Res (Hoboken). 2016 Apr;68(4):544-52 (Open Access). PMID: 26414460
  • Bautista-Molano W, Landewé RBM, Londoño J, Romero-Sanchez C, Valle-Oñate R, van der Heijde D. Analysis and performance of various classification criteria sets in a Colombian cohort of patients with spondyloarthritis. Clin Rheumatol. 2016 Jul;35(7):1759-67 (Open Access). PMID 26791876
  • Poddubnyy D, van Tubergen A, Landewé R, Sieper J, van der Heijde D, On behalf of the Assessment of SpondyloArthritis international Society (ASAS). Development of an ASAS-endorsed recommendation for the early referral of patients with a suspicion of axial spondyloarthritis. Ann Rheum Dis 2015;74:1483-7. (Toll-Free Link) PMID: 25990288
  • Wallis D, Thavaneswaran A, Haroon N, Ayearst R, Inman RD. Tumour necrosis factor inhibitor thearapy and infection risk in axial spondyloarthritis: results from a longitudinal observational cohort. Rheumatology (Oxford) 2015 Jan;54(1):152-6 (Open Access). PMID: 25125593
  • Kiltz U, van der Heijde D, Boonen A, Braun J. The ASAS Health Index (ASAS HI) – a new tool to assess the health status of patients with spondyloarthritis. Clin Exp Rheumatol. 2014;32:S-105-8 PMID: 25365097
  • Bautista-Molano W, Navarro-Compán V, Landewé RB, Boers M, Kirkham JJ, van der Heijde D. How well are the ASAS/OMERACT Core Outcome Sets for Ankylosing Spondylitis implemented in randomized clinical trials? A systematic literature review. Clin Rheumatol. 2014;33:1313-22 PMID: 24970597
  • Kiltz U, van der Heijde D, Boonen A, Cieza A, Stucki G, Khan MA, Maksymowych WP, Marzo-Ortega H, Reveille J, Stebbings S, Bostan C, Braun J. Development of a health index in patients with ankylosing spondylitis (ASAS HI): final result of a global initiative based on the ICF guided by ASAS. Ann Rheum Dis 2015;74:830-5. (Toll-Free Link) PMID: 24399232
  • Navarro-Compan V, de Miguel E, van der Heijde D, Landewé R, Almodóvar R, Montilla C, Beltrán E, Zarco P. Spondyloarthritis features forecasting the presence of HLA-B27 or sacroiliitis on magetic resonance imaging in patients with suspected axial spondyloarthritis: results from a cross-sectional study in the ESPeranza Cohort. Arthritis Res Ther 2015 Sep 23;17:265. PMID: 26395086
  • van den Berg R, de Hooge M, Rudwaleit M, Sieper J, van Gaalen F, Reijnierse M, Landewé R, Huizinga T, van der Heijde D. ASAS modification of the Berlin algorithm for diagnosing axial spondyloarthritis: results from the SPondyloArthritis Caught Early (SPACE)-cohort and from the Assessment of SpondyloArthritis international Society (ASAS)-cohort. Ann Rheum Dis 2013;72:1646-53. (Toll-Free Link) PMID: 23139266
  • Poddubnyy D, Gaydukova I, Hermann KG, Song IH, Braun J, Sieper J. Magnetic Resonance Imaging compared to conventional radiographs for detection of chronic structural changes in sacroiliac joints in axial spondyloarthritis. J Rheumatol 2013 Sep;40(9):1557-65 (Open Access). PMID: 23818713
  • Hermann KG, Baraliakos X, van der Heijde DM, Jurik AG, Landewé R, Marzo-Ortega H, Østergaard M, Rudwaleit M, Sieper J, Braun J. Assessment in SpondyloArthritis international Society (ASAS). Descriptions of spinal MRI lesions and definition of a positive MRI of the spine in axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI study group. Ann Rheum Dis 2012;71:1278-88. (Toll-Free Link) PMID: 22586174
  • van den Berg R, Baraliakos X, Braun J, van der Heijde D. First update of the current evidence for the management of ankylosing spondylitis with non-pharmacological treatment and non-biologic drugs: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis. Rheumatology (Oxford). 2012;51:1388-96. (Open Access) PMID: 22513148
  • Baraliakos X, van den Berg R, Braun J, van der Heijde D. Update of the literature review on treatment with biologics as a basis for the first update of the ASAS/EULAR management recommendations of ankylosing spondylitis. Rheumatology (Oxford). 2012 Aug;51(8):1378-87. (Open Access) PMID: 22427410
  • Dougados M, Braun J, Vargas RB, Gossec L, Maksymowych W, Sieper J, van der Heijde D. ASAS recommendations for variables to be collected in clinical trials/epidemiological studies of spondyloarthritis. Ann Rheum Dis 2012;71:1103-4. (Toll-Free Link) PMID: 22294624
  • Aydin SZ, Maksymowych WP, Bennett AN, McGonagle D, Emery P, Marzo-Ortega H. Validation of the ASAS criteria and definition of a positive MRI of the sacroiliac joint in an inception cohort of axial spondyloarthritis followed up for 8 years. Ann Rheum Dis. 2012;71:56-60. PMID: 21900284
  • van der Heijde D, Sieper J, Maksymowych WP, Dougados M, Burgos-Vargas R, Landewé R, Rudwaleit M, Braun J. Assessment of SpondyloArthritis international Society. 2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis. Ann Rheum Dis 2011 Jun;70(6):905-8. (Toll-Free Link) PMID: 21540200
  • Machado P, Landewé R, Lie E, Kvien TK, Braun J, Baker D, van der Heijde D, for the Assessment of Spondyloarthritis International Society. Ankylosing Spondylitis Disease Activity Score (ASDAS): Defining cut off levels for disease activity states and improvement scores. Ann Rheum Dis 2011:70:47-53. (Toll-Free Link) PMID: 21068095
  • Braun J, van den Berg R, Baraliakos X, Boehm H, Burgos-Vargas R, Collantes-Estevez E, Dagfinrud H, Dijkmans B, Dougados M, Emery P, Geher P, Hammoudeh M, Inman RD, Jongkees M, Khan MA, Kiltz U, Kvien T, Leirisalo-Repo M, Maksymowych WP, Olivieri I, Pavelka K, Sieper J, Stanislawska-Biernat E, Wendling D, Ozgocmen S, van Drogen C, van Royen B, van der Heijde D. 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 2011;70:896-904. (Open Access) PMID: 21540199
  • Dougados M, Simon P, Braun J, Burgos-Vargas R, Maksymowych WP, Sieper J, van der Heijde D. ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials/epidemiological studies in axial spondyloarthritis. Ann Rheum Dis 2011;70:249-51.(Toll-Free Link) PMID: 20829199
  • Rudwaleit M, van der Heijde D, Landewé R, Akkoc N, Brandt J, Chou CT, Dougados M, Huang F, Gu J, Kirazli Y, Van den Bosch F, Olivieri I, Roussou E, Scarpato S, Sørensen IJ, Valle-Oñate R, Weber U, Wei J, Sieper J. The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 2011;70:25-31. (Open Access) PMID: 21109520
  • Rudwaleit M, Jurik AG, Hermann KG, Landewé R, van der Heijde D, Baraliakos X, Marzo-Ortega H, Ostergaard M, Braun J, Sieper J. Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group. Ann Rheum Dis 2009;68:1520-7 (Toll-Free Link). PMID: 19454404
  • Rudwaleit M, Landewé R, van der Heijde D, Listing J, Brandt J, Braun J, Burgos-Vargas R, Collantes-Estevez E, Davis J, Dijkmans J, Dougados M, Emery P., van der Horst-Bruinsma IE, Inman R, Khan MA, Leirisario-Repo M, van der Linden S, Maksymowych WP, Mielants H, Olivieri I, Sturrock R, de Vlan K, Sieper J. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis 2009;68:770-76. PMID: 19297345
  • Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J, Braun J, Chou CT, Collantes-Estevez E, Dougados M, Huang F, Gu J, Khan MA, Kirazli Y, Maksymowych WP, Mielants H, Sørensen IJ, Ozgocmen S, Roussou E, Valle-Oñate R, Weber U, Wei J, Sieper J. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009;68:777-83 (Open Access). PMID: 19297344
  • Boonen A, Braun J, van der Horst Bruinsma IE, Huang F, Maksymowych W, Kostanjsek N, Cieza A, Stucki G, van der Heijde D. ASAS/WHO ICF Core Sets for ankylosing spondylitis (AS): how to classify the impact of AS on functioning and health. Ann Rheum Dis. 2010;69:102-7. PMID: 19282309
  • Sieper J, van der Heijde D, Landewé R, Brandt J, Burgos-Vagas R, Collantes-Estevez E, Dijkmans B, Dougados M, Khan MA, Leirisalo-Repo M, van der Linden S, Maksymowych WP, Mielants H, Olivieri I, Rudwaleit M. New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS). Ann Rheum Dis 2009;68:784-8. (Toll-Free Link) PMID: 19147614
  • van der Heijde D, Lie E, Kvien TK, Sieper J, Van den Bosch F, Listing J, Braun J, Landewé R; Assessment of SpondyloArthritis international Society (ASAS). ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis 2009;68:1811-8. (Toll-Free Link) PMID: 19060001
  • Kiltz U, van der Heijde D, Mielants H, Feldtkeller E, Braun J; PARE/EULAR patient initiative group. ASAS/EULAR recommendations for the management of ankylosing spondylitis: the patient version. Ann Rheum Dis. 2009;68:1381-6. (Open Access) PMID: 18930993
  • Lukas C, Landewé R, Sieper J, Dougados M, Davis J, Braun J, van der Linden S, van der Heijde D; Assessment of SpondyloArthritis international Society. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis. 2009;68:18-24. (Toll-Free Link) PMID: 18625618
  • Gossec L, Dougados M, Phillips C, Hammoudeh M, de Vlam K, Pavelka K, Pham T, Braun J, Sieper J, Olivieri I, van der Heijde D, Collantes E, Stone M, Kvien TK; ASAS (ASsessment in AS international working group). Dissemination and evaluation of the ASAS/EULAR recommendations for the management of ankylosing spondylitis: results of a study among 1507 rheumatologists. Ann Rheum Dis. 2008;67:782-8. (Toll-Free Link) PMID: 18055468
  • Lukas C, Braun J, van der Heijde D, Hermann KG, Rudwaleit M, Østergaard M, Oostveen A, O’Connor P, Maksymowych WP, Lambert RG, Jurik AG, Baraliakos X, Landewé R; ASAS/OMERACT MRI in AS Working Group. Scoring inflammatory activity of the spine by magnetic resonance imaging in ankylosing spondylitis: a multireader experiment. J Rheumatol. 2007;34:862-70. PMID: 17407241
  • Zochling J, van der Heijde D, Dougados M, Braun J. Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis. Ann Rheum Dis. 2006;65:423-32. (Open Access) PMID: 16126792
  • Zochling J, van der Heijde D, Burgos-Vargas R, Collantes E, Davis JC Jr, Dijkmans B, Dougados M, Géher P, Inman RD, Khan MA, Kvien TK, Leirisalo-Repo M, Olivieri I, Pavelka K, Sieper J, Stucki G, Sturrock RD, van der Linden S, Wendling D, Böhm H, van Royen BJ, Braun J; ‘ASsessment in AS’ international working group; European League Against Rheumatism. ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis. 2006;65:442-52. (Open Access) PMID: 16126791
  • Braun J, Davis J, Dougados M, Sieper J, van der Linden S, van der Heijde D; ASAS Working Group. First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis. Ann Rheum Dis. 2006;65:316-20. (Open Access) PMID: 16096329
  • van der Heijde D, Braun J, Landewé R, Davis J, Sieper J, van der Linden S, Dougados M. ASessment in Ankylosing Spondylitis (ASAS) international working group: a model for psoriatic arthritis and psoriasis? Ann Rheum Dis. 2005;64 Suppl 2:ii108-9. (Open Access) PMID: 15708922
  • Brandt J, Listing J, Sieper J, Rudwaleit M, van der Heijde D, Braun J. Development and preselection of criteria for short term improvement after anti-TNF alpha treatment in ankylosing spondylitis. Ann Rheum Dis. 2004;63:1438-44. (Open Access) PMID: 15044211
  • Braun J, Pham T, Sieper J, Davis J, van der Linden S, Dougados M, van der Heijde D; ASAS Working Group. International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis. Ann Rheum Dis. 2003;62:817-24. (Open Access) PMID: 12922952
  • Pham T, van der Heijde D, Calin A, Khan MA, van der Linden S, Bellamy N, Dougados M; ASAS Working Group. Initiation of biological agents in patients with ankylosing spondylitis: results of a Delphi study by the ASAS Group. Ann Rheum Dis. 2003;62:812-6. (Open Access) PMID: 12922951
  • van Tubergen A, van der Heijde D, Anderson J, Landewé R, Dougados M, Braun J, Bellamy N, Udrea G, van der Linden S. Comparison of statistically derived ASAS improvement criteria for ankylosing spondylitis with clinically relevant improvement according to an expert panel. Ann Rheum Dis. 2003;62:215-21. (Open Access) PMID: 12594105
  • Anderson JJ, Baron G, van der Heijde D, Felson DT, Dougados M. Ankylosing Spondylitis Assessment Group Preliminary Definition of Short-Term Improvement in Ankylosing Spondylitis. Arthritis Rheum 2001;44:1876-86. (Open Access) PMID: 11508441
  • van der Heijde D, van der Linden S, Dougados M, Bellamy N, Russell AS, Edmonds J. Ankylosing spondylitis: plenary discussion and results of voting on selection of domains and some specific instruments. J Rheumatol. 1999;26:1003-5. (Toll-Free Link) PMID: 10229437
  • van der Heijde D, van der Linden S, Bellamy N, Calin A, Dougados M, Khan MA. Which domains should be included in a core set for endpoints in ankylosing spondylitis? Introduction to the ankylosing spondylitis module of OMERACT IV. J Rheumatol. 1999;26:945-7 (Toll-Free Link). PMID: 10229424